British pharmaceutical giant GlaxoSmithKline PLC said it finally has its full team in place at its vaccine hub in Rockville, ready to take on some of the region’s most well-known biotech competitors with part of its product lineup. This next year, officials said, will be about taking a leadership position in new vaccine technologies and advancing its priority projects, including its vaccine for shingles as well its vaccine candidate for respiratory syncytial virus, a common respiratory virus that…
from https://www.bizjournals.com/baltimore/news/2017/12/08/glaxosmithklines-rockville-chief-lays-out.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/168321836852
No comments:
Post a Comment